Parkinson's Disease
1,265
86
114
819
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
241 trials with published results (19%)
Research Maturity
819 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
90 terminated out of 1265 trials
90.1%
+3.6% vs benchmark
15%
188 trials in Phase 3/4
29%
241 of 819 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 819 completed trials
Clinical Trials (1265)
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease
Agricultural Health Study Follow-up
Deep Brain Stimulation Therapy in Movement Disorders
PET Scanning in Parkinson s Disease
Auditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive Training
Clinical Laboratory Evaluation of Chronic Autonomic Failure
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Deep Brain Stimulation Surgery for Movement Disorders
Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease
Non-invasive VNS for Parkinson's Gait
Predictive Factors and Subthalamic Stimulation in Parkinson's Disease
rTMS to Improve Cognition in Parkinson's
Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease
At-home taVNS for Neurorehabilitation in Parkinson's Disease
The Swedish BioFINDER Sleep Study